CARDAMYST™ (etripamil) nasal spray, the first and only FDA-approved self-administered treatment for adults with paroxysmal supraventricular tachycardia (PSVT), is now available through U.S. retail pharmacies. For more information, please visit CARDAMYST.com.
CARDAMYST™ (etripamil) nasal spray, the first and only FDA-approved self-administered treatment for adults with paroxysmal supraventricular tachycardia (PSVT), is now available through U.S. retail pharmacies. For more information, please visit CARDAMYST.com.